Elevance Health, Inc. (ELV)
The price, the headline numbers and the latest news, in one place.
Elevance Health, Inc. (ELV) Stock Price, Analysis & Data
| Bid | 390.8 |
| Market Cap | 87.4B |
| Revenue (ttm) | 201B |
| Net Income (ttm) | 4.96B |
| 0.69 | |
| 23.22 | |
| 17.36 | |
| 13.61 | |
| P/B (ttm) | 1.95 |
| P/S (ttm) | 0.43 |
| Earnings Date | Oct 21, 2026 |
| Ask | 403.14 |
| Volume | 961,633 |
| Avg. Volume (20D) | 1,410,193 |
| Open | 396.44 |
| Previous Close | 392.54 |
| Day's Range | 393.57 - 404.82 |
| 52-Week Range | 274.84 - 436.24 |
| Analyst | Buy |
| Price Target | 457 (13.39%) |
| Dividends | $6.88 (1.75%) |
| Ex-Dividend Date | Sep 10, 2026 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care ser...
Financial Performance
In 2025, Elevance Health's revenue was 199.13B, an increase of 12.62% compared to the previous year's 176.81B. Earnings were 5.66B, a decrease of -5.32%.
Financial StatementsAnalyst Forecast
According to 21 analyst ratings, the average rating for ELV stock is "Buy". The 12-month stock price forecast is 457, which is upside of 13.39% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $50.47B misses estimates by $0, with 1.40% YoY growth.
- EPS of 7.45 exceeds estimates by 1.24, with -15.72% YoY decline.
Analysts project revenue of ... Upgrade
